Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

6. Miller J L. Neonatal Opioid Withdrawal Syndrome. ASHP. 2024

7. Patel K, Thomson S, Vijayan M, Makoni M, Johnson P N, Stephens K, Neely S, Miller J L. Vasopressin induced hyponatremia in infants <3 months of age in the neonatal intensive care unit. Frontiers in Pediatrics. 2024; 12 : 1-8

8. Chang E, Parman A, Johnson P N, Stephens K, Neely S, Dasari N, Kassa N, Miller J L. Gabapentin for Delirium in Infants in the Neonatal Intensive Care Unit. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2024; 29 : 487-493

9. Ropp D L, Johnson P N, Stephens K, Neely S, Chaaban H, Miller J L. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of perinatology : official journal of the California Perinatal Association. 2024; 44 : 1478-1484

10. Foote D, Miller J L, Skrepnek G H, Neely S, Harrison K, Boylan P. Montelukast deprescribing in outpatient specialty clinics: a single center cross-sectional study. Exploratory Research in Clinical and Social Pharmacy. 2024; 17 : 100509

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.


2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.


3. American Society of Health-System Pharmacists. Fellow of American Society of Health-System Pharmacists. Date: 2024.


4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


5. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Read More